Newsletter
12 de June de 2019
Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes
ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:
(i) the cultivation of the cannabis spp. for medical and scientific purposes; and
(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.
For further information, click below to access our full newsletter.
Back
Share:
Last related news
27 de August de 2025
Temporary Use of Unlicensed Software: Legal Liability Regardless of Duration
Companies often argue, during audits, that the use of unlicensed software occurred only briefly—over a few days or weeks—as a way to … Temporary Use of Unlicensed Software: Legal Liability Regardless of Duration
22 de August de 2025
Update from Brazil: The Debate on Platform Monetization and Accountability
A significant debate has recently emerged in Brazil following an episode involving the creator Felca. The controversy centered on the adultization of … Update from Brazil: The Debate on Platform Monetization and Accountability
21 de August de 2025
Public Consultation by the BPTO on Draft Guidelines for AI Inventions
On August 19, 2025, the Brazilian Patent and Trademark Office (BPTO) launched a public consultation on the draft Guidelines for the Examination … Public Consultation by the BPTO on Draft Guidelines for AI Inventions